Nils-Petter Rudqvist
9PUBLICATIONS
140CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Apr 18, 2025
Depletion of Effector Regulatory T Cells Associates with Major Response to Induction Dual Immune Checkpoint Blockade.Xianli Jiang, Nils-Petter Rudqvist, Bo Jiang
|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.Dhan Chand, David A Savitsky, Shanmugarajan Krishnan
|Aug 24, 2023
Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors.Nils-Petter Rudqvist, Maud Charpentier, Claire Lhuillier
|Jun 10, 2022
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.Rodney Cheng-En Hsieh, Sunil Krishnan, Ren-Chin Wu
|Apr 01, 2022
Hallmarks of Resistance to Immune-Checkpoint Inhibitors.Maria Karasarides, Alexandria P Cogdill, Paul B Robbins
|Mar 16, 2022
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer.Erik Wennerberg, Sumit Mukherjee, Sheila Spada
Pageof 2
Frequent Collaborators
3 joint publications
Xi Kathy Zhou
3 joint publications
Sandra Demaria
3 joint publications
Erik Wennerberg
2 joint publications
Silvia C Formenti
2 joint publications
Tuo Zhang
2 joint publications
Sheila Spada
2 joint publications
Michael A Curran
2 joint publications
Roberta Zappasodi
1 joint publications
Claire Vanpouille-Box
1 joint publications
Sacha Gnjatic
